Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04379505 · ClinicalTrials.gov registry record · NA
Palliative Expeditiously Adaptive Quad Shot Radiation Therapy (PEAQ-RT)
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04379505 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 10 participants.
The verdict
NCT04379505, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The investigators propose evaluating the feasibility of using the novel cone beam computed tomography (CBCT)-guided Ethos system to deliver expedited, adaptive Quad shot radiation for the purpose of palliative radiation of patients with advanced head and neck cancers or patients with a history of any malignancy experiencing current head and neck lesions. Quad shot radiation was selected as the palliative regimen of choice given its low toxicity profile, well published efficacy in palliation, frequent usage in the US for palliation of head and neck cancers, and safety in the setting of re-irradiation. The use of the Ethos platform to perform online adaptive radiation planning and delivery remains novel and untested. The Ethos system would be used to consolidate CT simulation, replanning, and treatment for Quad shot patients receiving treatment with the benefit of reduced patient travel and a reduction in the unwanted delay between Quad shot cycles. The goal of this pilot study will be to evaluate the feasibility of the Ethos system to eliminate the need for a CT simulation for cycles 2 and 3 of Quad shot radiation.
Interventions
- DEVICE Ring gantry kV-CBCT combined with linear accelerator (Halcyon)
- RADIATION Quad shot radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2023-12-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04379505
The ClinicalTrials.gov registry entry for NCT04379505 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ring gantry kV-CBCT combined with linear accelerator (Halcyon) is the first listed.
NCT04379505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04379505 about?
NCT04379505 is a clinical study titled "Palliative Expeditiously Adaptive Quad Shot Radiation Therapy (PEAQ-RT)". The investigators propose evaluating the feasibility of using the novel cone beam computed tomography (CBCT)-guided Ethos system to deliver expedited, adaptive Quad shot radiation for the purpose of palliative radiation of patients with advanced head and neck cancers or patients with a history of an...
What is the current status of trial NCT04379505?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-10-01. Estimated completion is 2023-12-05.
What interventions are being tested in trial NCT04379505?
The interventions under investigation include: Ring gantry kV-CBCT combined with linear accelerator (Halcyon) (DEVICE), Quad shot radiation (RADIATION).
Who is sponsoring clinical trial NCT04379505?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.